Adalat and Glaucoma - a phase IV clinical study of FDA data

Summary:

Glaucoma is reported as a side effect among people who take Adalat (nifedipine), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Vioxx, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Glaucoma when taking Adalat. It is created by eHealthMe based on reports of 20,643 people who have side effects when taking Adalat from the FDA, and is updated regularly.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,239 drugs and 1,652 conditions by eHealthMe. Check the latest studies of Glaucoma.

On May, 14, 2026

20,643 people reported to have side effects when taking Adalat.
Among them, 54 people (0.26%) have Glaucoma.

Among these 54 people:

How long have people been on Adalat when they have Glaucoma? *

What is the gender of people who have Glaucoma when taking Adalat? *

female: 81.13 %
male: 18.87 %

What is the age of people who have Glaucoma when taking Adalat? *

What are other drugs people take besides Adalat? *

What are other side effects people have besides Glaucoma? *

Dizziness: 20 people, 37.04%
Stress And Anxiety: 20 people, 37.04%
Cataract (clouding of the lens inside the eye): 20 people, 37.04%
Diarrhea: 19 people, 35.19%
Urinary Tract Infection: 19 people, 35.19%
Chest Pain: 18 people, 33.33%
Gait Disturbance: 18 people, 33.33%
Fatigue (feeling of tiredness): 17 people, 31.48%
Enlarged Heart: 17 people, 31.48%
Joint Pain: 17 people, 31.48%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 16 people, 29.63%
Depression: 6 people, 11.11%
Cardiac Disorder: 6 people, 11.11%
Hypersensitivity: 5 people, 9.26%
Diabetes: 5 people, 9.26%
Gastric Ulcer (stomach ulcer): 4 people, 7.41%
Stable Angina (a constant chest pain): 4 people, 7.41%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 7.41%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 4 people, 7.41%
Panic Disorder: 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Adalat and have Glaucoma?

- Check whether Glaucoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adalat:

Adalat (20,940 reports)

Glaucoma treatments and more:

Glaucoma (61,925 reports)

Browse all side effects of Adalat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glaucoma:

Glaucoma (1,239 drugs)

Browse all the conditions that are associated with Glaucoma:

Glaucoma (1,652 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on nifedipine (the active ingredients of Adalat) and Adalat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.